ICMR to begin study to evaluate BCG booster dose for kids, adolescents
This study will demonstrate the effect of BCG revaccination in comparison to oral chemoprophylaxis on the incidence of mycobacterium tuberculosis disease in healthy household contacts, aged 6-18 years
CHENNAI: Scientists at ICMR’s National Institute for Research in Tuberculosis in Chennai plan to initiate a study on BCG booster dose for kids and adolescents, who are household contacts of tuberculosis patients. The study aims to understand whether a booster BCG dose would prevent development of tuberculosis among them. For this, more than 9,000 children will be enrolled across seven sites in India.